Impact BioMedical, Inc. (IBO)
3.89
+0.34
(+9.58%)
USD |
NYAM |
Oct 28, 16:00
3.89
0.00 (0.00%)
After-Hours: 16:26
Impact BioMedical Free Cash Flow : -0.508M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.508M |
| March 31, 2026 | -1.672M |
| December 31, 2025 | -1.89M |
| September 30, 2025 | -3.245M |
| June 30, 2025 | -3.917M |
| March 31, 2025 | -4.119M |
| December 31, 2024 | -3.919M |
| September 30, 2024 | -3.096M |
| June 30, 2024 | -2.483M |
| Date | Value |
|---|---|
| March 31, 2024 | -2.332M |
| December 31, 2023 | -2.869M |
| September 30, 2023 | -3.075M |
| June 30, 2023 | -3.205M |
| March 31, 2023 | -3.004M |
| December 31, 2022 | -2.518M |
| September 30, 2022 | -2.669M |
| June 30, 2022 | -2.360M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| LENZ Therapeutics, Inc. | -114.42M |
| Enveric Biosciences, Inc. | -8.561M |
| ANI Pharmaceuticals, Inc. | 167.52M |
| Corcept Therapeutics, Inc. | 106.92M |
| Veru, Inc. | -26.04M |